182 related articles for article (PubMed ID: 22262178)
21. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
22. The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300.
Zimmermann H; Degenkolbe R; Bernard HU; O'Connor MJ
J Virol; 1999 Aug; 73(8):6209-19. PubMed ID: 10400710
[TBL] [Abstract][Full Text] [Related]
23. The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells.
Jeong Seo E; Jung Kim H; Jae Lee C; Tae Kang H; Seong Hwang E
Gynecol Oncol; 2004 Jul; 94(1):40-7. PubMed ID: 15262117
[TBL] [Abstract][Full Text] [Related]
24. The E2F5 repressor is an activator of E6/E7 transcription and of the S-phase entry in HPV18-associated cells.
Teissier S; Pang CL; Thierry F
Oncogene; 2010 Sep; 29(36):5061-70. PubMed ID: 20639900
[TBL] [Abstract][Full Text] [Related]
25. Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions.
von Knebel Doeberitz M; Rittmüller C; Aengeneyndt F; Jansen-Dürr P; Spitkovsky D
J Virol; 1994 May; 68(5):2811-21. PubMed ID: 8151752
[TBL] [Abstract][Full Text] [Related]
26. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
[TBL] [Abstract][Full Text] [Related]
27. CRISPR/Cas9-based inactivation of human papillomavirus oncogenes E6 or E7 induces senescence in cervical cancer cells.
Inturi R; Jemth P
Virology; 2021 Oct; 562():92-102. PubMed ID: 34280810
[TBL] [Abstract][Full Text] [Related]
28. The E8 repression domain can replace the E2 transactivation domain for growth inhibition of HeLa cells by papillomavirus E2 proteins.
Stubenrauch F; Straub E; Fertey J; Iftner T
Int J Cancer; 2007 Nov; 121(10):2284-92. PubMed ID: 17583574
[TBL] [Abstract][Full Text] [Related]
29. Transition to an irreversible state of senescence in HeLa cells arrested by repression of HPV E6 and E7 genes.
Kang HT; Lee CJ; Seo EJ; Bahn YJ; Kim HJ; Hwang ES
Mech Ageing Dev; 2004 Jan; 125(1):31-40. PubMed ID: 14706235
[TBL] [Abstract][Full Text] [Related]
30. Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer.
Fujii T; Saito M; Iwasaki E; Ochiya T; Takei Y; Hayashi S; Ono A; Hirao N; Nakamura M; Kubushiro K; Tsukazaki K; Aoki D
Int J Oncol; 2006 Sep; 29(3):541-8. PubMed ID: 16865269
[TBL] [Abstract][Full Text] [Related]
31. Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells.
Mahata S; Bharti AC; Shukla S; Tyagi A; Husain SA; Das BC
Mol Cancer; 2011 Apr; 10():39. PubMed ID: 21496227
[TBL] [Abstract][Full Text] [Related]
32. NF-Y loss triggers p53 stabilization and apoptosis in HPV18-positive cells by affecting E6 transcription.
Benatti P; Basile V; Dolfini D; Belluti S; Tomei M; Imbriano C
Oncotarget; 2016 Jul; 7(29):45901-45915. PubMed ID: 27323853
[TBL] [Abstract][Full Text] [Related]
33. Silencing of integrated human papillomavirus type 18 oncogene transcription in cells expressing SerpinB2.
Darnell GA; Antalis TM; Rose BR; Suhrbier A
J Virol; 2005 Apr; 79(7):4246-56. PubMed ID: 15767426
[TBL] [Abstract][Full Text] [Related]
34. Alpha-linolenic acid regulates Cox2/VEGF/MAP kinase pathway and decreases the expression of HPV oncoproteins E6/E7 through restoration of p53 and Rb expression in human cervical cancer cell lines.
Deshpande R; Mansara P; Kaul-Ghanekar R
Tumour Biol; 2016 Mar; 37(3):3295-305. PubMed ID: 26440049
[TBL] [Abstract][Full Text] [Related]
35. Down regulation of the interleukin-8 promoter by human papillomavirus type 16 E6 and E7 through effects on CREB binding protein/p300 and P/CAF.
Huang SM; McCance DJ
J Virol; 2002 Sep; 76(17):8710-21. PubMed ID: 12163591
[TBL] [Abstract][Full Text] [Related]
36. Nuclear matrix protein SMAR1 represses c-Fos-mediated HPV18 E6 transcription through alteration of chromatin histone deacetylation.
Chakraborty S; Das K; Saha S; Mazumdar M; Manna A; Chakraborty S; Mukherjee S; Khan P; Adhikary A; Mohanty S; Chattopadhyay S; Biswas SC; Sa G; Das T
J Biol Chem; 2014 Oct; 289(42):29074-85. PubMed ID: 25157104
[TBL] [Abstract][Full Text] [Related]
37. The activity of p53 is differentially regulated by Brm- and Brg1-containing SWI/SNF chromatin remodeling complexes.
Xu Y; Zhang J; Chen X
J Biol Chem; 2007 Dec; 282(52):37429-35. PubMed ID: 17938176
[TBL] [Abstract][Full Text] [Related]
38. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
[TBL] [Abstract][Full Text] [Related]
39. A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1.
Oike T; Ogiwara H; Tominaga Y; Ito K; Ando O; Tsuta K; Mizukami T; Shimada Y; Isomura H; Komachi M; Furuta K; Watanabe S; Nakano T; Yokota J; Kohno T
Cancer Res; 2013 Sep; 73(17):5508-18. PubMed ID: 23872584
[TBL] [Abstract][Full Text] [Related]
40. High-risk human papillomavirus-18 uses an mRNA sequence to synthesize oncoprotein E6 in tumors.
García A; Maldonado G; González JL; Svitkin Y; Cantú D; García-Carrancá A; Sonenberg N; Hernández G
Proc Natl Acad Sci U S A; 2021 Oct; 118(41):. PubMed ID: 34615711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
